Author

E. Montaudon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Animal Behavior & Cognition· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Organism:human· 2 Approach:biophysical modeling· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:organoid / primary culture· 1

Frequent Co-Authors

E. Marangoni· 3 shared A. Dahmani· 2 shared A.-S. Mace· 1 shared B. Piqueret· 1 shared C. Colombero· 1 shared C. Ercan· 1 shared C. K. Ng· 1 shared C. Lengerke· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

E. Marangoni

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Ants act as olfactory bio-detectors of tumour in patient-derived xenograft mice

B. Piqueret, E. Montaudon, P. Devienne, C. Leroy, E. Marangoni, J.-C. Sandoz, P. d'Ettorre

This study shows ants can be trained to detect tumour-specific VOCs in mice urine, indicating their potential as cancer bio-detectors.

bioRxiv · May 16, 2022Animal Behavior & Cognition

mTOR repression in response to amino acid starvation promotes ECM degradation through MT1-MMP endocytosis arrest

C. Colombero, D. Remy, S. Antoine, A.-S. Mace, P. Monteiro, N. ElKhatib, M. Fournier, A. Dahmani, E. Montaudon, G. Montagnac, E. Marangoni, P. Chavrier

The paper shows that mTOR repression during amino acid starvation leads to increased ECM degradation via MT1-MMP endocytosis arrest in tumor cells.

bioRxiv · Jan 29, 2021Cancer Biology

GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers

G. Bianco, M. Coto Llerena, J. Gallon, S. Taha-Mehlitz, V. Kancherla, M. Konantz, S. Srivatsa, H. Montazeri, F. Panebianco, M. De Menna, V. Paradiso, C. Ercan, A. Dahmani, E. Montaudon, N. Beerenwinkel, , S. Piscuoglio

This study identifies GATA3 and MDM2 as synthetic lethal in ER-positive breast cancers, showing MDM2 inhibition can target GATA3-deficient tumors via the PI3K/Akt/mTOR pathway.

bioRxiv · May 18, 2020Cancer Biology